What does postradiotherapy PSA nadir tell us about freedom from PSA failure and progression-free survival in patients with low and intermediate-risk localized prostate cancer?

Author: DeWitt K.D.   Sandler H.M.   Weinberg V.   McLaughlin P.W.   Roach M.  

Publisher: Elsevier

ISSN: 0090-4295

Source: Urology, Vol.62, Iss.3, 2003-09, pp. : 492-496

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content